Association between HLA class II antigens and hepatitis C virus infection

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 4, 2003, Pages 316-321

  Scotto, Gaetano ^a,d   Fazio, V ^b   D'Allessandro, G ^a   Monno, L ^c   Saracino, A ^a   Palumbo, E ^a   Angarano, G ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Hospital of Foggia   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d NONE   (Italy)

Author keywords

HLA class II; Virus C related hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC IDENTIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER INJURY; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTION; PROGNOSIS; SEROPREVALENCE; SEROTYPING; TISSUE INJURY; VIRUS LOAD;

HEPATITIS C VIRUS;

EID: 1842423604     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. EASL International Consensus Conference on Hepatitis C. Consensus Statement. J Hepatol 1999; 31: 3-8.
2. Prati D, Capelli C, Silvani C, et al. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 1997; 25: 702-4.
3. Di Bisceglie AM. Hepatitis C. Lancet 1998; 351: 351-5.
4. Seef LB. Natural history of hepatitis C. Hepatology 1997; 26 (Suppl): S21-8.
5. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 344: 1475-9.
6. Gordon SC, Elloway RS, Dumchowski CF. The patology of hepatitis C as a function of mode of transmission: Blood transfusion versus intravenous drug use. Hepatology 1993; 18: 1338-43.
7. Dusheiko G, Schmilowitz Weiss H, Brown D, McOmish F, Yap PI, et al. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13-8.
8. Okada SI, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the aminoterminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619-24.
9. Diepolder HM, Zachovel R, Hoffmann R, et al. Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-7.
10. Shakil AO, Conry Cantilena C, Alter HJ, et al. Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic and histologic features. The hepatitis C Study group. Ann Intern Med 1995; 123: 330-7.
11. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRE, METAVIR, CLINIVIR and DOSVIR groups. Lancet 1997; 349: 825-32.
12. Botarelli P, Brunetto MR, Minutello MA, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580-4.
13. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson P. Association between HLA class II genotype and spontaneous clearance of hepatitis C viremia. J Hepatol 1998; 29: 214-23.
14. Alric L, Fort M, Izopat J, et al. Genes of major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 1675-81.
15. Minnton EJ, Smillie D, Neal KR, Irwing WL, Underwood JC, James V and Members of the Trent Hepatitis C Virus Study Group. Association between HLA class II alleles and clearance of circulating hepatitis C virus. J Infect Dis 1998; 178: 39-44.
16. Zavaglia C, Martinetti M, Silini E, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998; 28: 1-7.
17. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 19: 431-5.
18. Ishak KG, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
19. Terasaki P, Gjertson D, eds. HLA 1997: Los Angeles, USA: UCLA Tissue Typing Laboratory 1997; 213.
20. Barrett S, Ryan E, Crowe J. Association of the HLA-DRB101 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 1999; 30: 979-83.
21. Ferrari C, Valli A, Galati L, et al. T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-95.
22. Cramp ME, Carucci P, Chokshi S. A multispecie T-lymphocyte response to hepatitis C virus proteins occurs in patients with viral clearance and persists many years after exposure (abstract). Hepatology 1996; 24: 252.
23. Ceppellini R, Frumento G, Ferrara GB, Tosi R, Chersi A, Pernis B. Binding of labelled influenza matrix peptide to HLA-DR in living B lymphoid cells. Nature 1989; 339: 392-4.
24. Haruma Y, Miyamoto T, Yasunai R, Kauda T, Fushimi H, Kotoh K. Human leukocyte antigen DRB11302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C. J Hepatol 2000; 32: 837-42.
25. Peano G, Messardi G, Pozzetto A, Fenoglio LM. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994; 154: 2733-6.
26. Zavaglia C, Bortolon C, Ferrioli G, et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996; 24: 658-65.
27. Thio CL, Thomas DL, Goedert J, et al. Racial differences in HLA class II associations with hepatitis C virus outcome. J Infect Dis 2001; 184: 16-21.
28. Godkin A, Jeanguet N, Thursz M, Openshau P, Thomas H. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. J Immunol 2001; 31: 1438-46.
29. Kryczka W, Brojer E, Kalinska A, Urbaniak A, Zarebska-Michaluk D. DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C. Med Sci Monit 2001; 7 (Suppl.): S217-20.
30. Hue S, Cacoub P, Renou C, et al. Human leucocyte antigen class II alleles may contribute to the severity of hepatitis C virus related liver disease. J Infest Dis 2002; 186: 106-9.
31. Renou C, Halfon P, Pol S, et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alaninr aminotransferase levels. GUT 2002; 51: 585-90.